Retinal fluorescence lifetime imaging ophthalmoscopy measures depend on the severity of Alzheimer's disease

To determine alterations in the retina of patients with Alzheimer's disease (AD) by the newly developed technique of fluorescence lifetime imaging ophthalmoscopy (FLIO) in a pilot study.

[1]  J. S. McCasland,et al.  Metabolic Mapping , 2000, Current protocols in neuroscience.

[2]  G. Hajak,et al.  Cerebrospinal fluid tau and β-amyloid in Alzheimer patients, disease controls and an age-matched random sample , 2006, Neurobiology of Aging.

[3]  N. Gupta,et al.  Retinal tau pathology in human glaucomas. , 2008, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[4]  W. D. Oswald,et al.  Psychometrics in aging and dementia: advances in geropsychological assessments. , 1985, Archives of gerontology and geriatrics.

[5]  A. Chorvatova,et al.  Multi-wavelength fluorescence lifetime spectroscopy: a new approach to the study of endogenous fluorescence in living cells and tissues , 2009 .

[6]  J. Fischer,et al.  Vergleich von Parametern der zeitaufgelösten Autofluoreszenz bei Gesunden und Patienten mit früher AMD , 2009, Der Ophthalmologe.

[7]  J. Morris.  The Clinical Dementia Rating (CDR) , 1993, Neurology.

[8]  J. Lakowicz,et al.  Fluorescence lifetime imaging of free and protein-bound NADH. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[9]  J D Hares,et al.  Fluorescence lifetime imaging with picosecond resolution for biomedical applications. , 1998, Optics letters.

[10]  E. Mufson,et al.  Beta-amyloid deposition and functional impairment in the retina of the APPswe/PS1DeltaE9 transgenic mouse model of Alzheimer's disease. , 2009, Investigative ophthalmology & visual science.

[11]  R. Gans,et al.  Simple non-invasive assessment of advanced glycation endproduct accumulation , 2004, Diabetologia.

[12]  D. Schweitzer,et al.  Detection of early metabolic alterations in the ocular fundus of diabetic patients by time-resolved autofluorescence of endogenous fluorophores , 2011, European Conference on Biomedical Optics.

[13]  R. Ramponi,et al.  Time-resolved fluorescence spectroscopy of the retinal pigment epithelium: age-related studies , 1990 .

[14]  A. Heikal.  Intracellular coenzymes as natural biomarkers for metabolic activities and mitochondrial anomalies. , 2010, Biomarkers in medicine.

[15]  Samuel B. Guze,et al.  Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV) , 1995 .

[16]  Edward A. Boettner,et al.  Transmission of the Ocular Media , 1962 .

[17]  Karsten König,et al.  Clinical multiphoton tomography , 2008, Journal of biophotonics.

[18]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[19]  K Svanberg,et al.  FLUORESCENCE IMAGING AND POINT MEASUREMENTS OF TISSUE: APPLICATIONS TO THE DEMARCATION OF MALIGNANT TUMORS AND ATHEROSCLEROTIC LESIONS FROM NORMAL TISSUE , 1991, Photochemistry and photobiology.

[20]  D. Schweitzer,et al.  Time-resolved autofluorescence imaging of human donor retina tissue from donors with significant extramacular drusen. , 2012, Investigative ophthalmology & visual science.

[21]  Hans G Lemij,et al.  Diagnostic accuracy of the GDx VCC for glaucoma. , 2004, Ophthalmology.

[22]  N. Ramanujam,et al.  Metabolic mapping of MCF10A human breast cells via multiphoton fluorescence lifetime imaging of the coenzyme NADH. , 2005, Cancer research.

[23]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[24]  M. Moschos,et al.  Structural and functional impairment of the retina and optic nerve in Alzheimer's disease. , 2012, Current Alzheimer research.

[25]  Dietrich Schweitzer,et al.  Two-photon excited fluorescence microscopy application for ex vivo investigation of ocular fundus samples , 2011, European Conference on Biomedical Optics.

[26]  Xinqing Zhang,et al.  Retinal nerve fiber layer structure abnormalities in early Alzheimer's disease: Evidence in optical coherence tomography , 2010, Neuroscience Letters.

[27]  Amos D. Korczyn,et al.  Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease , 2011, Clinical Neurology and Neurosurgery.

[28]  W. Becker.  Fluorescence lifetime imaging – techniques and applications , 2012, Journal of microscopy.

[29]  K. Ashe,et al.  Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease. , 2008, Investigative ophthalmology & visual science.

[30]  M Hammer,et al.  [Comparison of parameters of time-resolved autofluorescence between healthy subjects and patients suffering from early AMD]. , 2009, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

[31]  M. Tso,et al.  Immunoreactivity against tau, amyloid precursor protein, and beta-amyloid in the human retina. , 1995, Investigative ophthalmology & visual science.

[32]  Johannes Kornhuber,et al.  Combined CSF tau, p-tau181 and amyloid-β 38/40/42 for diagnosing Alzheimer’s disease , 2009, Journal of Neural Transmission.

[33]  Serkan Kirbas,et al.  Retinal Nerve Fiber Layer Thickness in Patients With Alzheimer Disease , 2013, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[34]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.

[35]  J. Féher,et al.  Mitochondrial alterations of retinal pigment epithelium in age-related macular degeneration , 2006, Neurobiology of Aging.

[36]  J. Lakowicz.  Principles of fluorescence spectroscopy , 1983 .

[37]  Claire Paquet,et al.  Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease , 2007, Neuroscience Letters.

[38]  K. Nakanishi,et al.  A2E, a lipofuscin fluorophore, in human retinal pigmented epithelial cells in culture. , 1999, Investigative ophthalmology & visual science.

[39]  N. Yüksel,et al.  Relationship between Cognitive Impairment and Retinal Morphological and Visual Functional Abnormalities in Alzheimer Disease , 2006, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[40]  D. Schweitzer,et al.  Towards metabolic mapping of the human retina , 2007, Microscopy research and technique.

[41]  S. Achilefu,et al.  Fluorescence lifetime measurements and biological imaging. , 2010, Chemical reviews.

[42]  J. Caprioli,et al.  Optical coherence tomography to detect and manage retinal disease and glaucoma. , 2004, American journal of ophthalmology.

[43]  E. Bézard,et al.  Protein Aggregation in the Aging Retina , 2011, Journal of neuropathology and experimental neurology.

[44]  Ronald C Petersen,et al.  Mild cognitive impairment: current research and clinical implications. , 2007, Seminars in neurology.